Cas 916213-05-3,5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid

916213-05-3

Post Buying Request

Basic information

Product Name: 5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid
Synonyms: 5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid
CAS NO:916213-05-3
Molecular Formula:
Molecular Weight: 366.711
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid(CAS DataBase Reference)
NIST Chemistry Reference: 5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid(916213-05-3)
EPA Substance Registry System: 5-(3-chloro-4-fluorobenzylcarbamoyl)-3-fluoropyrazolo[1,5-a]pyrimidine-7-carboxylic acid(916213-05-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 916213-05-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

916213-05-3 Suppliers

Recommended suppliers

916213-05-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 916213-05-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,6,2,1 and 3 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 916213-05:
(8*9)+(7*1)+(6*6)+(5*2)+(4*1)+(3*3)+(2*0)+(1*5)=143
143 % 10 = 3
So 916213-05-3 is a valid CAS Registry Number.

916213-05-3Upstream product

916213-05-3Downstream Products

1030019-58-9 C₂₀H₁₇ClF₂N₆O₂

916213-05-3Relevant academic research and scientific papers

HETEROBICYCLIC METALLOPROTEASE INHIBITORS

-

Page/Page column 255, (2008/06/13)

The present invention relates generally to amide group containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic MMP- 13 inhibiting compounds, that exhibit an increased potency in relation to currently known MMP- 13 inhibitors.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 916213-05-3